Procurement
Expert Panel
Create New Account
Login
logo
Report store
Insights
Survey
Consulting
Book discovery call
logo

Cognitive Behavioral Therapy Market: Current Analysis and Forecast (2021-2027)

Region:Global

Product Code:UMHE21286

Download Sample Report
Published On

July 2021

Total pages

149

About the Report

Cognitive Behavioural Therapy (CBT) is a type of psychotherapy for the treatment of different mental health-related problems such as anxiety disorders, mood disorders, substance abuse disorders, personality disorders, and attention deficit disorders. These therapies are performed to substitute the bad habits with the good ones and to help the person to manage difficult situations in life.

The demand for Cognitive Behavioural Therapy is mainly increasing on account of the rising incidences of obsessive-compulsive disorder (OCD), increasing cases of depression, Increased awareness regarding mental health & available therapeutic options, and escalating bad behaviors among teen individuals. As per the Anxiety and Depression Association of America (2020), around 2.3% of the population has OCD, which is about 1 in 100 children and 1 in 40 adults in the U.S.

However, some of the restraints in the market include limited access to mental health care providers and a lack of knowledge regarding mental health in less developed countries.

Based on Type, the market is fragmented into Cognitive Behavioral Therapy, Cognitive Behavioral Play Therapy, System, Desensitization, Aversion Therapy, and Others. Cognitive Behavioral Therapy accounted for the largest share in 2020 is anticipated to register a lucrative CAGR during the forecast period. As the name indicates, Cognitive Behavioral Therapy includes two main components such as cognitive therapy which investigates how negative thoughts contribute to anxiety, and behavior therapy investigates how you behave and react in situations that trigger anxiety. The rising prevalence of mental health disorders such as anxiety disorders, depression, substance abuse, PTSD (post-traumatic stress disorder) propels the market growth. As per the World Health Organization (2020), Depression is the leading cause of disability in the world, and more than 264 million people suffer from depression worldwide.

Based on Applications, the market is fragmented into anxiety disorders, depression, substance abuse, PTSD (Post-Traumatic Stress Disorder), eating disorders, ADHD (attention deficit hyperactivity disorder), bipolar disorders, and others. The anxiety disorders segment registered the highest CAGR in 2019 Substance Abuse Disorders is expected to register the highest CAGR during the forecast period, owing to an increase in the prevalence of substance abuse of people staying at home during the lockdown, and rise in illegal business of abuse drugs post unemployment. As per the National Survey on Drug Use and Health (NSDUH), 19.7 million American adults (aged 12 and older) were suffering from substance use disorder in 2017.

Based on Patient Type, the market is fragmented into Children and Adults. The Adult segment accounted for the largest share in 2020 is anticipated to register a lucrative CAGR during the forecast period owing to the high prevalence of mental disorders and bad lifestyles. As per the Our World in Data, more than a quarter (26.3%) of adults aged 18 to 25 years old had a mental health disease in 2018.

Based on Treatment Settings, the market is fragmented into Hospitals, Outpatient Clinics, Community Health Centers, and Others. The Outpatient Clinics dominated the market in 2019 and is anticipated to register the highest growth in the forecast period. The flexibility of the outpatient clinics makes it feasible for the patient to attend the appointment during the daytime and to be with their family in the evenings. As per a study conducted by the American Journal of Psychiatry, with the adoption of Electronic Health Records (EHR) in the outpatient clinic the number of suicide deaths can be prevented. The increase in outpatient clinics for mental health facilities also propels the market growth. As per Statista, there were 5,220 outpatient mental health facilities in the U.S. in 2019.

For a better understanding of the market adoption of Cognitive Behavioural Therapy, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the Cognitive Behavioural Therapy market on account of the rising mental health disorders, rising number of mental health clinics, and high awareness regarding mental health. As per the National Institute of Mental Health, there were approximately 51.5 million adults aged 18 or above in the United States with Any mental illness (AMI). This number represented 20.6% of all U.S. adults. Some of the major players operating in the market include Allergan, Inc., Novartis AG, Taro Pharmaceutical Industries Ltd., Perrigo Company plc, Zynerba Pharmaceuticals, Apotex Inc., Sandoz AG, Strides Arcolab Ltd., TOLMAR Pharmaceuticals, Inc., Limbix. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Scope of the Report

Products

Cognitive Behavioural Therapy (CBT) is a type of psychotherapy for the treatment of different mental health-related problems such as anxiety disorders, mood disorders, substance abuse disorders.

Companies

Allergan, Inc., Novartis AG, Taro Pharmaceutical Industries Ltd., Perrigo Company plc, Zynerba Pharmaceuticals, Apotex Inc., Sandoz AG, Strides Arcolab Ltd., TOLMAR Pharmaceuticals, Inc., Limbix

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Limitations

1.3. Stake Holders

1.4. Currency Used in Report

2 RESEARCH PROCESS & RESEARCH METHODOLOGY

2.1. Research Process of the Cognitive Behavior Therapy Market

2.2. Research Methodology of the Cognitive Behavior Therapy Market

2.3. Forecasting Method

2.4. Respondent Profile

2.5. Main Objective of the Cognitive Behavior Therapy Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL COGNITIVE BEHAVIOR THERAPY MARKET ANALYSIS 2019-27F

6 MARKET INSIGHTS BY TYPE

6.1. Cognitive Behavioral Therapy

6.2. Cognitive Behavioral Play Therapy

6.3. System Desensitization

6.4. Aversion Therapy

6.5. Others

7 MARKET INSIGHTS BY APPLICATION

7.1. Anxiety Disorders

7.2. Depression

7.3. Substance Abuse

7.4. PTSD (Post-Traumatic Stress Disorder)

7.5. Eating Disorders

7.6. ADHD (Attention Deficit Hyperactivity Disorder)

7.7. Bipolar disorders

7.8. Others

8 MARKET INSIGHTS BY PATIENT TYPE

8.1. Children

8.2. Adult

9 MARKET INSIGHTS BY TREATMENT SETTINGS

9.1. Hospitals

9.2. Outpatient Clinics

9.3. Community Health Centers

9.4. Others

10 MARKET INSIGHTS BY REGION

10.1. NORTH AMERICA COGNITIVE BEHAVIOR THERAPY MARKET

10.1.1. United States

10.1.2. Canada

10.1.3. Rest of North America

10.2. EUROPE COGNITIVE BEHAVIOR THERAPY MARKET

10.2.1. Germany

10.2.2. France

10.2.3. United Kingdom

10.2.4. Italy

10.2.5. Spain

10.2.6. Rest of Europe

10.3. ASIA PACIFIC COGNITIVE BEHAVIOR THERAPY MARKET

10.3.1. China

10.3.2. Japan

10.3.3. India

10.3.4. Australia

10.3.5. Rest of Asia Pacific

10.4. REST OF WORLD COGNITIVE BEHAVIOR THERAPY MARKET

11 DEMAND AND SUPPLY SIDE ANALYSIS

12 VALUE CHAIN ANALYSIS

13 COGNITIVE BEHAVIOR THERAPY MARKET TRENDS & INSIGHTS

14 COGNITIVE BEHAVIOR THERAPY MARKET DYNAMICS

14.1. Drivers

14.2. Challenges

14.3. Impact Analysis

15 COGNITIVE BEHAVIOR THERAPY MARKET OPPORTUNITIES

16 COMPETITIVE SCENARIO

17 COMPANY PROFILED

17.1. Allergan, Inc.

17.2. Novartis AG

17.3. Taro Pharmaceutical Industries Ltd.

17.4. Perrigo Company plc

17.5. Zynerba Pharmaceuticals

17.6. Apotex Inc.

17.7. Sandoz AG

17.8. Strides Arcolab Ltd.

17.9. TOLMAR Pharmaceuticals, Inc.

17.10. Limbix

18 DISCLAIMER

Research Methodology

Why Buy From Us?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022